COCRYSTAL PHARMA, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
COCRYSTAL PHARMA, INC. (COCP) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 20 shares for the 6-month period ending 2019-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-08-06
- COCRYSTAL PHARMA, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-03-31 was 26.00K shares.
- COCRYSTAL PHARMA, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 2.57K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month |
|---|---|---|---|---|---|
| 2019-06-30 | 20.00 shares 10-Q · filed 2020-08-06 | 20.00K shares 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 26.00K shares 10-Q · filed 2020-05-13 | 26.00 shares 10-Q · filed 2019-05-10 | |||
| 2016-09-30 | 783.00 shares 10-Q · filed 2016-11-09 | ||||
| 2015-09-30 | 2.57K shares 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |